Late-Breaking Clinical Trials and First Report Investigations
Late-Breaking Clinical Trials
Submission Opens: July 5, 2017
Submission Deadline: August 21, 2017 (2 PM ET)
Late-Breaking Clinical Trials are typically first-time international or US presentations of the primary endpoint or important secondary endpoint results of prospective randomized clinical trials or of large-scale, impactful single-center or multicenter registries. Accepted Late-Breaking Clinical Trial submissions will be presented in the Main Arena at TCT 2017 and during press conferences scheduled on the same days as the Main Arena presentations. First Report investigations are typically early experiences with novel devices or drugs. The following rarely qualify as Late-Breaking Clinical Trial (or even First Report Investigation) submissions: pre-clinical studies, early first-in-human device studies, and meta-analyses; these should be submitted as Abstracts or as Interventional Innovations.
If you have questions or need clarification, please contact Margaret Zetts at the following email address: email@example.com